Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2007 Aug 14.

Published in final edited form as: Toxicon. 2007 Jan 10;49(7):899–908. doi: 10.1016/j.toxicon.2006.12.013

Fig. 2 — (A) In vitro wound closure assays on different ECM. The closure of untreated control was taken to be 100%. The percent of control was calculated by dividing the distance that treated cell had migrated by the distance that untreated cells had migrated. The values represent the means (± SE, vertical bars) of nine independent experiments. (B) Eristostatin inhibits in vitro closure of melanoma cells on fibronectin matrix in a concentration-dependent manner. The percent wound closures of treated cells was calculated as above. The values represent the means (± SE, vertical bars) of nine independent experiments. * p < 0.05

Fig. 2 — (A) In vitro wound closure assays on different ECM. The closure of untreated control was taken to be 100%. The percent of control was calculated by dividing the distance that treated cell had migrated by the distance that untreated cells had migrated. The values represent the means (± SE, vertical bars) of nine independent experiments. (B) Eristostatin inhibits in vitro closure of melanoma cells on fibronectin matrix in a concentration-dependent manner. The percent wound closures of treated cells was calculated as above. The values represent the means (± SE, vertical bars) of nine independent experiments. * p < 0.05